SCHEMBL29480755

SCHEMBL29480755

CN1CCC(C(O)(c2ccc(-n3cc(-c4ccnc(N)c4N)cn3)nc2)C(F)(F)F)CC1

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MELK Q14680 8/20 0.33
▸ GRM4 Q14833 2/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31
▸ ABL1 P00519 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ PDGFRA P16234 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ HASPIN Q8TF76 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ GCK P35557 1/20 0.31
▸ ACVR1 Q04771 2/20 0.30
▸ RPS6KB1 P23443 1/20 0.30
▸ MET P08581 1/20 0.30
▸ KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22736355 1.00 MELK (0.33) MELKGRM4HDAC4KDM4EABL1
SCHEMBL29480654 0.93 GRM4 (0.35) GRM4HDAC4KDM4EABL1LMNA
SCHEMBL29480769 0.90 MAP3K7 (0.37) GRM4HDAC4ACVR1MET
SCHEMBL22735955 0.90 MAP3K7 (0.37) GRM4HDAC4ACVR1MET
SCHEMBL22736147 0.89 CYP3A4 (0.31) HDAC4CYP3A4CYP2D6GCK
SCHEMBL29480757 0.89 CYP3A4 (0.31) HDAC4CYP3A4CYP2D6GCK
SCHEMBL22735904 0.84 KDM4A (0.36) MELKGRM4HDAC4PDGFRAFLT3
SCHEMBL29480485 0.84 KDM4A (0.36) MELKGRM4HDAC4PDGFRAFLT3
SCHEMBL22735757 0.81 HDAC4 (0.33) GRM4HDAC4KDM4EABL1LMNA
SCHEMBL29480733 0.81 HDAC4 (0.33) GRM4HDAC4KDM4EABL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976612-A1 NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 MANKIND PHARMA LTD (IN) 2022-04-06 — — EP disclosed
CN-114174294-A Novel compounds for inhibiting JANUS kinase 1 人类制药有限公司 2022-03-11 — — CN disclosed
Send feedback